Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Cardurion Pharmaceuticals Inc.

Headquarters: Boston, MA, United States of America
Year Founded: 2017
Status: Private

BioCentury | Mar 7, 2025
Management Tracks

Abbas Kazimi succeeds Jeb Keiper as CEO of Nimbus

Plus: Jon Garay Alonso named CFO of Almirall, and updates from Certara and Immunai
BioCentury | Jul 18, 2024
Finance

Venture Report: Five biotechs raise nearly $800M in two-day flurry 

Plus: New capital for CytoReason, Truvian and Renalys
BioCentury | Jan 20, 2023
Management Tracks

Radcliffe becomes new CFO at Cardurion

Plus: Granaturova becomes COO and CBO at Normunity, and updates from 
BioCentury | Sep 8, 2022
Product Development

Sept. 8 Quick Takes: Detailed APOLLO-B data lift Alnylam shares

Plus Autobahn heads for treatment-resistant depression with $32M round and updates on Amylyx, Reata, Integral Molecular and more 
BioCentury | Feb 17, 2022
Management Tracks

New leadership for Merck’s human health business 

Plus new CEOs at Renibus and Indapta, updates from Milestone, Briacell and more
Items per page:
1 - 5 of 5